Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer Watchers Try To Read New CEO's Next Moves

Executive Summary

Pfizer, Inc.,'s abrupt management shake-up, announced Dec. 5, comes almost a year to the day its key drug Lipitor goes off patent. Whether the timing of the changes was a coincidence or the result of accumulating pressures, the patent expiration date of November 2011 is a marker for new CEO Ian Read and portends additional changes at the world's largest drug manufacturer.

Related Content

Changes Ahead For Pfizer, But Don't Expect A "Big Bang," Read Says
Deals Of The Week: Cephalon/Mesoblast; GSK/MeiRui; Geron/Angiochem…
Deals Of The Week: Cephalon/Mesoblast; GSK/MeiRui; Geron/Angiochem…
Pfizer Turns To Insider Ian Read To See It Into Post-Lipitor Era
Pharma's Health Reform Deal: Kindler Departure Facilitates GOP Re-Alignment
Merck's Frazier Promoted to CEO to Steer Merck To Post-Schering Success
Pfizer Clears Out Pipeline: After Oncology Disappointments, Talks Up Diabetes
Crizotinib Holds Promise For Lung Cancer, And For Pfizer Oncology
Pfizer’s Business Units Enable It To Be Nimble Even as It Grows
Pfizer Set For “Fundamental And Sustained” Change Under New CEO Kindler





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts